Latest news with #3DICOMMD

Herald Sun
24-06-2025
- Business
- Herald Sun
Long Shortz: Singular Health Group
Don't miss out on the headlines from Stockhead. Followed categories will be added to My News. Stockhead's Tylah Tully chats with Singular Health Group (ASX:SHG) chief operating officer Martina Mariano, after the company secured its first US enterprise commercial contract with Provider Network Solutions, a managed service organisation covering over 3.7 million members. The $2 million deal includes the rollout of its 3DICOM MD platform and AI diagnostic integration across Florida, Texas, and Puerto Rico. This agreement not only addresses the costly issue of duplicate imaging in healthcare but also marks a strategic entry point into the US market, unlocking future national expansion opportunities. Watch the video to learn more. This video was developed in collaboration with Singular Health Group, a Stockhead advertiser at the time of publishing. The interviews and discussions in this video are opinions only and not financial or investment advice. Viewers should obtain independent advice based on their own circumstances before making any financial decisions. Originally published as Long Shortz with Singular Health: Reinforcing its place in the US market


West Australian
19-06-2025
- Business
- West Australian
Singular seals US deal to roll out 3D medical imaging platform
Singular Health has added a feather to its cap by securing a US$1.3 million (A$2M) commercial deal with United States healthcare group Provider Network Solutions (PNS). The company has also raised $8 million to bankroll a national rollout of its AI-driven 3D medical imaging platform across the US. Singular says three major challenges continue to hobble the US healthcare system - redundant medical imaging, slow disease detection and fragmented access to patient data. The company's 3D medical imaging platform - dubbed 3DICOM MD - has been purpose-built to solve these issues by streamlining access to medical scans across multiple servers, thereby reducing duplication, saving time, cutting costs and improving outcomes. It has also already been cleared for diagnostic use in the US. The new contract follows a year-long collaboration with PNS that started with a memorandum of understanding in November last year. The project has now evolved into a full-blown rollout backed by both parties. The breakthrough deal will see Singular push out its US$800 (A$1230) platforms to 1000 doctors within the PNS network. PNS manages more than 3.7 million patients stretched across Florida, Texas and Puerto Rico. The deal also attracts an additional success fee of US$500,000 (A$768,000) when PNS signs off on the satisfactory integration of its AI model and centralised image repository. A successful implementation could potentially leverage PNS's partner network in 30 additional states and open the door to a much larger-scale nationwide rollout. Singular says the landmark deal is a massive shot in the arm, giving it a solid beachhead in the lucrative US healthcare market ahead of a much bigger national push. The company is eyeing a jaw-dropping US$19 billion (A$29.2B) annual market opportunity, with 1.3 million doctors typically linked to 19 separate managed service organisations. To support its growth strategy Singular has also locked in firm commitments for a heavily supported $8 million placement at 35 cents per share, which is a modest 4.6 per cent discount on its recent trading average. The company says the capital raising attracted strong interest from institutional investors and high-net-worth backers, with both PNS and existing investor Marin & Sons tinning up to support the placement. PNS chief executive officer and founder Dr Jose Pelayo praised the technology as a smarter, more efficient way to fix duplicate imaging. With a strong war chest, now sitting at nearly $13 million after the latest capital raising, powerful allies and a proven tech platform now gaining traction in the world's largest healthcare market, Singular Health may be about to rewrite the rules on medical imaging – in 3D. Is your ASX-listed company doing something interesting? Contact: